openPR Logo
Press release

PDX Models Market Competitive landscape analysis 2018-2025: The Jackson Laboratory, Champions Oncology, Inc., Oncodesign, WuXi AppTec, Horizon Discovery, Pharmatest Services, MI Bioresearch, Crown Bioscience, Inc., Charles River Laboratories

10-03-2018 04:40 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

PDX Models Market

PDX Models Market

PDX Models report provides a comprehensive analysis of the PDX Models market sales by showing all the figures in the historic and base year while also showing what the approximate figures are going to be in the forecast years of 2018-2025.

The report also provides with a deep explanation on what the market definition, classifications, applications, and engagements are. By making it clear on how the key players and brands are moving in terms of their sales, import, export and revenue and what their actions are in terms of their recent product launches, their researches, their joint ventures, merges, and accusations.

The report consists with all the company profiles along with the market drivers and restrains with the help of SWOT analysis.

Looking for more information on this market? Get Free sample report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-pdx-models-market

Global PDX Models Market is expected to reach USD 275.58 million by 2025 and is projected to register a CAGR of healthy rate in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

The global PDX models market highly concentrated to a few big players and rest to local players who cater to domestic markets only. Charles River dominated the PDX models market accounting for a highest market share in 2017, followed by Crown Bioscience Inc. and Champion Oncology, Inc. Other players in this market include are The Jackson Laboratory, Oncodesign, Wuxi Apptec, Horizon Discovery Group plc, Pharma test Services Ltd, Aragen Bioscience (Subsidiary of GVK Biosciences Private Limited), MI Bioresearch Inc., EUROPDX, Creative Animodel, Urolead, Xentech, Hera BioLabs and EPO BERLIN-BUCH GMBH among others.

Charles River:

Founded in 1947 and headquartered in Massachusetts, U.S. Company is mainly focuses on basic research, discovery, safety and efficacy, clinical support and manufacturing of drugs. It deals into different products and services research models and services, discovery services, safety assessment, laboratory sciences, biologics testing solutions, avian vaccine services, QC microbial solutions, training, staffing and operations support. It has its business segments into DSA, RMS and manufacturing. The company has its geographical presence into U.S, Europe, Canada, Asia- Pacific and other.

In October, 2017, Charles river (U.S.) came into in partnership with InSphero AG. (Switzerland) In this the company extended its collection of PDX tumors to Insphero and leverage InSphero’s 3D cell culture technology. This partnership extended company’s pre-clinical service portfolio.
Crown Bioscience Inc.:

Founded in 2006 and headquartered in California, U.S. offers drug discovery and development services to biotech and pharmaceutical partners focusing on oncology and metabolic disease therapeutic areas. The company is completely engaged in providing products and services antibodies, cells, biochemicals, reference standards, recombinat proteins TMA’S, kits and reagents.

The company is based in U.S, U.K, China and Taiwan.

Champion Oncology, Inc.:

Founded in 1985 and has its headquarters in New Jersey, U.S. The company offers end-to-end research and development solutions and services to improve the productivity of oncology drug development. It has its business segment into personalized oncology solutions and Translational oncology solutions. The company is engaged in products and services solutions, products and personalized oncology. It has its presence in U.S. and U.K.

Browse Detailed TOC, Tables and Figures @ http://databridgemarketresearch.com/toc/?dbmr=global-pdx-models-market

Segmentation: Global PDX Models Market

Global PDX Models Market, By Type (Mice Models, Rat Models), Tumor Type (Respiratory Tumor Models, Urological Tumor Models, Gastrointestinal Tumor Models, Hematological Tumor Models, Gynecological Tumor Models, Others), Application (Preclinical Drug Development & Oncology Research, Biomarker Analysis), End User (Contract Research Organization, Academic & Research Institutions, Pharmaceutical & Biotechnology Companies), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2025

Drivers: Global PDX Models Market

Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization.

RISING NUMBER OF PHARMACEUTICAL R&D ACTIVITIES IN CANCER RESEARCH

Cancer is the second most death causing disease in people around the world. According to the study by WHO, there were almost 8.8 million deaths noted due to the cancer in the year 2015 globally. In low- and middle-income countries, 70.0% of deaths are due to cancer. Due to rising cancer prevalence worldwide, the healthcare sector and organizations (both public and private) are investing huge amount of money to carry out various scientific researches to develop novel drugs and technology to treat disease. Government bodies across are investing heavily in research activities for advancements in the field of cancer across the globe. Biotech and pharma companies are accelerating drug development activities in the oncology sector. According to the International Federation of Pharmaceutical Manufacturers & Associations key facts 2017, pharmaceutical industry currently spends over USD 149.8 Billion on R&D activities per year.

Patient Derived Xenograft (PDX) models are majorly used by pharmaceutical and biotechnology companies as models for oncology research. These models provide various aspects of genesis, progression, and clinical course of human cancers. PDX models are generated by transplanting fresh human tumor specimen from a cancer patient into a mouse or rat. Therefore, these models give near accurate assessment of human tumor biology, identification of therapeutic targets, preclinical screening, and evaluation of drugs for various cancers.

According to the article published by THE JACKSON LABORATORY, cancer research is going to get help in improving data sharing and reproducibility. This will be possible through the new minimal information standard for Patient Derived Xenograft (PDX) models, which will make the models easy to find, access, integrate and reuse which are highly used in research.

THE JACKSON LABORATORY is also spending in R&D programs. In 2017, they tripled their investments from previous year. Below mentioned are the investment stats for the amount spent by the company for new research and development.

In 2017, Oncodesign (France), which is a biopharma company dedicated to the precision medicine, invested around 16.15 million USD in 2017 for the research and development activities, which was almost double investment from the previous year.

Is there any query or specific requirements? Ask to our Industry Expert @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-pdx-models-market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PDX Models Market Competitive landscape analysis 2018-2025: The Jackson Laboratory, Champions Oncology, Inc., Oncodesign, WuXi AppTec, Horizon Discovery, Pharmatest Services, MI Bioresearch, Crown Bioscience, Inc., Charles River Laboratories here

News-ID: 1278098 • Views:

More Releases from Data Bridge Market Research

Vitamin K Market IS growing at a CAGR of 6.8% during the forecast period of 2023 to 2030
Vitamin K Market IS growing at a CAGR of 6.8% during the forecast period of 2023 …
Vitamin K Market Analysis and Size The essential factors contributing to the growth of the market in the forecast period of 2023 to 2020 include growing demand for vitamin supplements, changing dietary patterns, and rising health consciousness. Data Bridge Market Research analyses that the global vitamin K market, which was USD 841.47 million in 2022, is expected to reach USD 1,410.20 million by 2030, growing at a CAGR of 6.8% during the
Transformer Oil Market is expected to undergo a CAGR of 7.55% by 2029
Transformer Oil Market is expected to undergo a CAGR of 7.55% by 2029
Transformer Oil Market Analysis and Size Transformers are almost everywhere, and every power and distribution transformer is filled with the dielectric insulating fluid, which consists high resistance to electricity and cools the transformer. The "bio based oil" is the highest growing type segment because it has better resistance to fire as compared to other oil over the forecast period. Furthermore, the growth of electric grids in developing economies and the upgradation
 Fatty Alcohols Market is expected to undergo a CAGR of 5.15% by 2029
 Fatty Alcohols Market is expected to undergo a CAGR of 5.15% by 2029
Fatty Alcohols Market Analysis and Size The rising demand of hygiene product coupled with growing consumer awareness is anticipated to drive the personal care industry and boost the growth of the fatty alcohols market. Fatty alcohols are used as emollients, emulsifiers and catalytic hydrogenation in cosmetics and beauty products. The "C11-C14 fatty alcohols" is the fastest growing product segment because it is used to produce sodium laureth ether sulphate (SLES), a major foaming agent
Exclusive Insights on Gusseted Bags Market Latest Trends, Drivers, Strategies and Competitive Landscape Top Players Analysis Industry Trends and Forecast
Exclusive Insights on Gusseted Bags Market Latest Trends, Drivers, Strategies an …
An important Gusseted Bags Market research report is produced by taking into account every requirement that organizations need to meet in order to expand successfully. This market report forecasts the market size based on data on major retailer sales, industry growth by upstream and downstream factors, industry advancement, major players, market segments, and application. When creating the reliable Gusseted Bags Market study, the goals of the marketing research are taken into

All 5 Releases


More Releases for PDX

Patient-Derived Xenograft/PDX Model Market - Global Trends, Share Analysis, Lead …
This study involved four major activities in estimating the current size of the PDX model market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After
2022 PDX Models Market Report- Rising Trend, Demand Opportunity and Detailed Out …
PDX Models Market report comprehensively encompasses vital information on the global market and covers significant factors affecting the PDX Models Market growth during the forecast period. PDX Models Market report offers tailored content to be easily understood by the stakeholders, new entrants, existing players, and individuals operating in the market. PDX Models Market report coverage provides data related to market offerings, drivers, restraints, and growth opportunities striving in the PDX
Global Health Care Operations Software Market: Emerging Trends, Major Key Player …
According to the report, The global health care operations software market size is expected to grow from $ in 2020 to $ Million by 2028 growing at the CAGR of 15.2% from 2021 to 2028. Some major factors are driving the global Health Care Operations Software market such as growing hospitals, rising adoption of electronic health records in hospitals, increasing government initiatives for patient data sharing and the increasing requirement
PDX models Market: Increasing Demand for Personalized Medicine to Fuel the Growt …
The proposed PDX models Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics. The PDX models Market sample report includes an exclusive analysis
Global Patient Derived Xenograft/PDX Models Market Driven by Recent Development …
Qyresearchreports include new market research report "Global Patient Derived Xenograft/PDX Models Market Size,Status and Forecast 2025" to its huge collection of research reports. The report on the Patient Derived Xenograft/PDX Models is divided into various segments which provides a better understanding to the readers. The report caters an overall supply chain of the market with complete details. This report consists of statistical information accompanied and special focus on various downstream and
Patient Derived Xenograft/PDX Models Market Segmentation and Competitor Analysis …
Patient derived tumor xenograft are created when the cancerous tissue from the primary tumor of the patient is directly implanted into an immunodeficient mouse. This technique provides solutions to challenges in cancer drug research such as positive tumor responses There is an increase in research and development activities in the oncology sector to understand and develop better techniques. This report studies the current and future aspects of the patient derived